Selenium and selenium-antagonistic elements in nutritional cancer prevention.
Selenium is an essential trace element with antioxidative, antimutagenic, antiviral and anticarcinogenic properties. There is increasing evidence that the dietary selenium intakes are sub-optimal in the populations of many countries and that human cancer mortalities would significantly decline if additional selenium was made available either through supplementation or the fortification of certain foods. An important property of selenium is its interaction with other elements that may be present in foods, the water, the workplace and the environment, e.g. As, Cu, Ni, Co, Cr, Mn, Zn, Cd, Sn, Pb, Hg, Bi, Mo, Ag, Au, etc. The sequestration of elements by selenium represents an efficient natural detoxification mechanism for some of these elements but also results in the physiological inactivation of selenium. Animal experiments confirm that the chronic exposure to low levels of these elements abolishes the cancer-protective effect of selenium. Human cancer is likewise significantly determined by the interactions of selenium with other elements, as evidenced by epidemiological, ecological and case-control studies. Cadmium, for example, is a key risk-increasing element for prostate cancer; for breast cancer, Cd, Cr, Zn are mainly contributing; for bronchial cancer (in smelter workers), Cd, As, Cr, Sb, Co, La, all these elements are in a reciprocal relationship with Se. While selenium remains the key cancer-protective trace element, the interpretation of its mode of action necessitates consideration of the effects of selenium antagonistic elements.
Schrauzer
G N
GN
Department of Chemistry and Biochemistry, University of California-San Diego, La Jolla, CA, USA. gschrauzer@ucsd.edu
D000818:Animals; D016588:Anticarcinogenic Agents / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000627:therapeutic use; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000517:prevention & control*; D040242:Risk Reduction Behavior; D012643:Selenium / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000627:therapeutic use
D016588:Anticarcinogenic Agents; D012643:Selenium